Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Australia
(14/week)
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Guatemala
(0/week)
View all
(14/week)
News
United States
(593/week)
Manufacturing
(401/week)
Energy
(303/week)
Technology
(414/week)
Environment
(248/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Eisai Co., Ltd.
Jul 13, 2020
Initiation Of New Phase III Clinical Study (AHEAD 3-45) Of BAN2401 Preclinical (Asymptomatic) Alzheimer's Disease
Sep 13, 2019
Eisai And Biogen To Discontinue Phase III Clinical Studies Of BACE Inhibitor Elenbecestat In Early Alzheimer's Disease
May 28, 2019
Eisai to Present Eight Lemborexant Posters at SLEEP 2019 Meeting, Including New Pooled Analyses From Phase 3 Studies and New Phase 1 Data
Jan 07, 2019
Arena Pharmaceuticals Reports Positive Long-Term Data from the Open-Label Extension of the Phase 2 OASIS Trial Evaluating Etrasimod for Treatment of Ulcerative Colitis
Oct 17, 2018
Eisai and Purdue Pharma Announce Positive Topline Results of SUNRISE 2, the Second Phase 3 Pivotal Study of Lemborexant
Jul 25, 2018
Eisai And Biogen Announce Detailed Results Of Phase II Clinical Study Of BAN2401 In Early Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018
Jul 25, 2018
Eisai And Biogen Present Detailed Results From Phase II Clinical Study Of Elenbecestat In MCI And Mild To Moderate Alzheimer's Disease At Alzheimer's Association International Conference (AAIC) 2018
Jul 05, 2018
Eisai And Biogen Announce Positive Topline Results Of The Final Analysis For BAN2401 At 18 Months
Jun 05, 2018
Positive New Data on Investigational Lemborexant Presented at 32nd Annual SLEEP Meeting
Mar 07, 2018
Eisai and Purdue Pharma Announce Positive Topline Results From Key Clinical Studies of Lemborexant Including First-Ever Phase 3 Head-to-Head Superiority Comparison Versus Zolpidem ER in Patients With Sleep Disorder
Sep 25, 2017
Michael Amoroso appointed Senior Vice President, Americas Commercial, Oncology Business Group at Eisai Inc.
Latest News
Apr 24, 2024
Rocket Lab Successfully Deploys Satellites ~500km Apart to Separate Orbits For KAIST and NASA
Apr 24, 2024
Sturm, Ruger & Company, Inc. to Report First Quarter 2024 Financial Results on Tuesday, May 7
Apr 24, 2024
Encore Wire Reports First Quarter Results
Apr 24, 2024
Novo Oil & Gas II Receives Equity Capital Commitment from EnCap Investments
Apr 24, 2024
Advent Technologies Holdings Receives Nasdaq Notice on Late Filing of its Form 10-K
Apr 24, 2024
Ranger Energy Services, Inc. Announces Date for First Quarter 2024 Earnings Conference Call
Apr 24, 2024
Crescent Energy Schedules First Quarter 2024 Earnings Release and Conference Call
Apr 24, 2024
American States Water Company to Report First Quarter 2024 Results
View all News
Agenda
17
June
France
Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024, 17 - 21 June 2024, Parc des Expositions de Paris Nord Villepinte ZAC Paris Nord 2, 93420 Villepinte – France (Halls 5a – 5b – 6)
Eurosatory 2024 There can be no sustainable world without peace and security. Founded in 1967, the exhibition...
21
May
Paris Marriott Rive Gauche & Conference Center
Future Artillery, 21-23 May 2024, Paris Marriott Rive Gauche & Conference Center, France
DELIVERING FIRES IN THE MULTI-DOMAIN BATTLESPACE As artillery reasserts itself as the ‘King of Battlefield’ in the wake...
21
May
United Arab Emirates
ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR Abu Dhabi 2024, 21-23 May 2024, ADNEC (Abu Dhabi National Exhibition Centre), Abu Dhabi, Al Khaleej Al Arabi St - Al Rawdah - Al Ma'arid - Abu Dhabi, UAE
ISNR ACCELERATING TRANSFORMATION IN THE NATIONAL SECURITY ECOSYSTEM ISNR Abu Dhabi is the region’s most trusted...
View All Events